BAINBRIDGE, Ga. - Danimer Scientific, Inc. (NYSE: DNMR), a company specializing in biodegradable materials, has announced a registered direct offering involving the sale of 15 million shares of common stock and accompanying warrants. The shares and stock equivalents are priced at $1.00 each, with warrants exercisable at $1.33 per share starting six months post-issuance and...
NEW YORK - Intelligent Group Limited, a Hong Kong-based financial public relations company, has set the price for its initial public offering (IPO) at $4 per ordinary share. The shares are expected to begin trading on the Nasdaq Capital Market today under the ticker symbol NASDAQ:INTJ, with the offering anticipated to close on March 22,...
In a recent transaction, Jennifer Kayden Lee, the Executive Vice President and Head of North America at Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), sold 15,515 shares of company stock. The sales were conducted at prices ranging from $39.07 to $39.22, with the total value of the shares sold amounting to approximately $608,498. This sale was carried out...
In a recent SEC filing, Robert W. D\'Loren, CEO and Chairman of XCel Brands Inc. (NASDAQ:XELB), reported purchasing shares of the company\'s common stock. The transaction, dated March 15, 2024, involved the acquisition of 146,250 shares at a price of $0.65 per share, amounting to a total investment of approximately $95,062. This purchase by the...
Shawn Marie Soderberg, the Chief Legal Officer and Corporate Secretary of Bloom Energy Corp (NYSE:BE), has recently engaged in transactions involving the company\'s stock, according to the latest SEC filings. Soderberg sold a total of 2,160 shares of Class A Common Stock at an average price of $9.31, netting a total of $20,109. The transactions...
In a recent transaction on March 19, Yann Mazabraud, EVP and Head of International at Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), sold 16,000 shares of the company\'s common stock. The total value of the stock sold amounted to $627,520, with the shares being sold at a weighted average price of $39.22. The price range for these transactions...
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) has reported a significant transaction involving its Chief Technical Officer, Joseph Shulman. On March 19, 2024, Shulman sold 15,515 shares of the company\'s common stock, accruing over $608,000 from the sale. The shares were sold at prices ranging from $39.06 to $39.22, with a weighted average price of $39.22 per share....
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) CEO David P. Meeker has sold a portion of his stock in the company, according to a recent filing with the Securities and Exchange Commission. The transaction, which took place on March 19, 2024, involved the sale of 45,494 shares at a weighted average price of $39.22, resulting in a total...
Investors following Arthur J. Gallagher & Co. (NYSE:AJG) might be interested in the recent transactions made by company Vice President Joel D. Cavaness. According to the latest SEC filings, Cavaness has sold shares worth over $308,000. The transactions, which took place on March 18, 2024, involved the sale of 1,207 shares at an average price...
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Chief Financial Officer Hunter C. Smith has sold a total of 15,515 shares of common stock, with the transactions valued at over $600,000. The sales took place on March 19, 2024, and were executed at a weighted average price of $39.22 per share. The price range for these transactions was between...